# Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease

> **NCT00819143** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 3 (actual)

## Conditions studied

- Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00819143
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-29
- **Primary completion:** —
- **Final completion:** 2011-07-13
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819143, "Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00819143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*